Stay updated on Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial

Sign up to get notified when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 is added to the history and the previous v3.3.1 entry is removed.
    Difference
    0.1%
    Check dated 2025-12-01T16:17:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The latest history shows a new entry Revision: v3.3.1 added and Revision: v3.2.0 removed, reflecting a minor page revision. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:35:57.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    - The banner about lapse in government funding and operating status updates has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T06:17:38.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    New version entries appear in the Record History, adding updates to study status, recruitment status, and contacts/locations for the trial. These entries document ongoing changes to the trial record.
    Difference
    0.1%
    Check dated 2025-11-03T00:53:57.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page now communicates current operating status amid funding lapses and publicly states the new version v3.2.0, replacing the old v3.1.0.
    Difference
    10%
    Check dated 2025-10-05T09:21:36.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Released a new version: v3.1.0, replacing the old v3.0.2. This is a version upgrade with potential feature/bug fix implications, but no other substantive content changes were detected.
    Difference
    0.2%
    Check dated 2025-09-28T03:06:03.000Z thumbnail image

Stay in the know with updates to Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.